Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma

Clinical trial NCT04523688 · RECRUITING

Trial details

NCT number: NCT04523688
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Vaccination

Start date: 2021-03-25
Primary completion: 2025-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.